Development of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AIDS Malignancy Consortium
With
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
The Emmes Company, LLC
PRIMARY OBJECTIVES:
I. To develop a Spanish-language version of the anal cancer/high-grade squamous intraepithelial lesions outcomes research (ANCHOR) high-grade squamous intraepithelial lesions (HSIL) health-related quality of life (HRQoL) index (HQI) using state-of-the-art measure development methodology that captures the most important HRQoL symptoms and concerns of those persons diagnosed with anal HSIL and either treated or untreated for anal HSIL.
OUTLINE:
Participants take part in cognitive interviews in Spanish over 45-60 minutes.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Human immunodeficiency virus (HIV)-1 infection.
Biopsy-proven anal HSIL within the prior nine months.
Participant must have received anal HSIL treatment in the last nine months. If the participant's treatment plan is observation? the participant must have been diagnosed with anal HSIL in the last nine months.
Life expectancy of greater than 5 years.
Fluent in Spanish with limited English proficiency, per self-report.
You may not be if
History of anal cancer.
Inability to understand a written consent form.
Clareo Health | Development of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions
